<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03284398</url>
  </required_header>
  <id_info>
    <org_study_id>3CBs-001-CNI</org_study_id>
    <nct_id>NCT03284398</nct_id>
  </id_info>
  <brief_title>Three-Chamber Bags Retrospective Study in Spain</brief_title>
  <official_title>Observational Retrospective Analysis Assessing the Influence of Three-Chamber Bags Compared to Hospital Compounded Parenteral Nutrition Bags on Blood Stream Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresenius Kabi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary study objective is to assess the rates of blood stream infection (BSI) from the&#xD;
      use of Three-Chamber Bags (e.g., SmofKabiven®, Kabiven®, others) compared to Hospital&#xD;
      Compounded Bags (HCBs) in patients requiring parenteral nutrition in Spanish hospitals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective observational database study of patients receiving parenteral&#xD;
      nutrition (PN) for at least 3 consecutive days with hospital admission date between January&#xD;
      1, 2013, and December 31, 2015 (study period).&#xD;
&#xD;
      The study will use an as treated approach, where patients will be followed from the index&#xD;
      date (hospital admission day of the hospitalization during which PN is administered) up to&#xD;
      patient discharge or death (observation period).&#xD;
&#xD;
      The study will be conducted using an initial EMR (Electronic Medical Record) data retrieval&#xD;
      process, followed by manual data retrieval (chart review) that will complement data obtained&#xD;
      from EMR. Data collection for manual data retrieval will be conducted through an eCRF.&#xD;
&#xD;
      The documentation of patient data will comprise two sequential steps. The initial step will&#xD;
      include data of 30% of patients and then an interim analysis (IA) will be conducted. If IA&#xD;
      shows positive results, data for the remaining 70% of patients (step II) will be gathered.&#xD;
&#xD;
      The study will be conducted in 10-14 sites in Spain.&#xD;
&#xD;
      Data analysis: Baseline demographics, co-morbidities, and hospitalization characteristics&#xD;
      will be reported descriptively by means of mean with standard deviations and medians with&#xD;
      ranges for continuous variables and by counts and percentages for categorical variables.&#xD;
      Incidence rates for BSI will be reported by treatment group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 14, 2017</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Patients Presenting With a Confirmed Microbial Blood Stream Infection During Treatment With PN for Each Group (3CB vs HCB)</measure>
    <time_frame>Entire study period, from January 1, 2013 and December 31, 2015</time_frame>
    <description>Confirmation of BSI required fulfillment of all of the following criteria:&#xD;
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) code for sepsis (038.x), septicemia (995.91), severe sepsis (995.92), septic shock (785.52), bacteremia (790.7), unspecified infection due to central venous catheter (999.31), or BSI due to central venous catheter (999.32)&#xD;
Positive blood culture collected during PN administration&#xD;
Concomitant antimicrobial therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sepsis During PN</measure>
    <time_frame>From date of admission to date of discharge</time_frame>
    <description>Percentage of patients presenting at least one episode of Sepsis during treatment with PN for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment With Antimicrobials During PN</measure>
    <time_frame>Any day during PN treatment</time_frame>
    <description>Percentage of patients receiving antimicrobial agents during treatment with PN for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Vasopressor Treatment</measure>
    <time_frame>Patients requiring vasopressor support at any time during treatment with PN</time_frame>
    <description>Percentages of patients requiring vasopressor support during PN treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Mechanical Ventilation</measure>
    <time_frame>Patients requiring mechanical ventilation at any time during PN treatment</time_frame>
    <description>Percentage of patients requiring mechanical ventilation during PN treatment for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Replacement Therapy</measure>
    <time_frame>Patients requiring renal replacement therapy for at least one day during PN treatment</time_frame>
    <description>Percentage of patients requiring Renal Replacement Therapy during PN treatment for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newly-occurred Abnormal Laboratory Findings During PN</measure>
    <time_frame>During PN treatment inclusive day 1</time_frame>
    <description>Percentage of patients presenting newly-occurred abnormal laboratory results during PN for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Organ Failure</measure>
    <time_frame>Any time during PN treatment</time_frame>
    <description>Percentage of patients presenting at least one organ failure during treatment with PN for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay (LOS)</measure>
    <time_frame>Duration in days from admission to death or discharge for each treatment arm</time_frame>
    <description>Hospital length of stay in days for patients for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in the ICU</measure>
    <time_frame>All patients admitted in the ICU at any time during PN treatment</time_frame>
    <description>Total number of days in the ICU for each group (3CB vs HCB)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3723</enrollment>
  <condition>Parenteral Nutrition</condition>
  <condition>Blood Stream Infection</condition>
  <arm_group>
    <arm_group_label>Parenteral nutrition bag type</arm_group_label>
    <description>Groups with different parenteral nutrition bags (3CBs or HCBs)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Population will include adult hospitalized patients receiving PN, treated on any ward and&#xD;
        by any medical discipline within the hospital (e.g., intensive care unit, normal wards;&#xD;
        surgery, non-surgery) during the study period. For every patient, one hospitalization&#xD;
        episode will be documented.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult hospital inpatients ≥ 18 years&#xD;
&#xD;
          2. Treatment with PN for at least 3 consecutive days&#xD;
&#xD;
          3. PN containing all three major macronutrients, delivered from 3CB or HCB&#xD;
&#xD;
          4. Patients with hospital admission between January 1, 2013, and December 31, 2015 (study&#xD;
             period)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Bloodstream infection before or at the same day of first PN administration&#xD;
&#xD;
          2. Immunosuppression due to concomitant therapy (e.g., immunosuppressive therapy due to&#xD;
             transplantation, concomitant oral or intravenous administration of glucocorticoids) or&#xD;
             disease (e.g., HIV, leukaemia)&#xD;
&#xD;
          3. Permanent vascular access (port, shunts for dialysis)&#xD;
&#xD;
          4. Femoral venous placement of central venous line used for PN&#xD;
&#xD;
          5. Burns, extensive skin injuries (e.g., Lyell´s disease)&#xD;
&#xD;
          6. Chemo-/radiotherapy for up to 3 months before hospital admission&#xD;
&#xD;
          7. Change of PN bag type during observation period, e.g., from HCBs to 3CBs or vice-versa&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John F Stover</last_name>
    <role>Study Chair</role>
    <affiliation>Fresenius Kabi Deutschland GmbH, Borkenberg 14, 61440 Oberursel, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Carlos M González</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario 12 de Octubre, 28041 Madrid, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Manacor</name>
      <address>
        <city>Manacor</city>
        <state>Islas Baleares</state>
        <zip>7500</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 4, 2017</study_first_submitted>
  <study_first_submitted_qc>September 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 15, 2017</study_first_posted>
  <results_first_submitted>August 6, 2020</results_first_submitted>
  <results_first_submitted_qc>December 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 8, 2021</results_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>parenteral nutrition</keyword>
  <keyword>ICU</keyword>
  <keyword>3-chamber bags</keyword>
  <keyword>ICD-9-CM</keyword>
  <keyword>BSI</keyword>
  <keyword>Medical records system</keyword>
  <keyword>computerized</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 18, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/98/NCT03284398/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Retrospective cohort study. Data collection from medical records</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Three-chambered Bag (3CB)</title>
          <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via an industrially-compounded three-chambered PN bag for ≥3 consecutive days during the study period</description>
        </group>
        <group group_id="P2">
          <title>Hospital-Compounded Bag (HCB)</title>
          <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via a Hospital-compounded all-in-one PN bag for ≥3 consecutive days during the study period</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2753"/>
                <participants group_id="P2" count="970"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2753"/>
                <participants group_id="P2" count="970"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>A total of 5389 patient records were screened for eligibility; of these, 3723 met the selection criteria, including 2753 patients who received 3CB and 970 patients who received MCB</population>
      <group_list>
        <group group_id="B1">
          <title>Three-Chambered Bag (3CB)</title>
          <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
        </group>
        <group group_id="B2">
          <title>Hospital-compounded Bag (HCB)</title>
          <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2753"/>
            <count group_id="B2" value="970"/>
            <count group_id="B3" value="3723"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2753"/>
                    <count group_id="B2" value="970"/>
                    <count group_id="B3" value="3723"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.8" spread="15.2"/>
                    <measurement group_id="B2" value="66.5" spread="14.8"/>
                    <measurement group_id="B3" value="66.8" spread="15.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2753"/>
                    <count group_id="B2" value="970"/>
                    <count group_id="B3" value="3723"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1144"/>
                    <measurement group_id="B2" value="354"/>
                    <measurement group_id="B3" value="1498"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1609"/>
                    <measurement group_id="B2" value="616"/>
                    <measurement group_id="B3" value="2225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2753"/>
                    <count group_id="B2" value="970"/>
                    <count group_id="B3" value="3723"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2753"/>
                    <measurement group_id="B2" value="970"/>
                    <measurement group_id="B3" value="3723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients Presenting With a Confirmed Microbial Blood Stream Infection During Treatment With PN for Each Group (3CB vs HCB)</title>
        <description>Confirmation of BSI required fulfillment of all of the following criteria:&#xD;
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) code for sepsis (038.x), septicemia (995.91), severe sepsis (995.92), septic shock (785.52), bacteremia (790.7), unspecified infection due to central venous catheter (999.31), or BSI due to central venous catheter (999.32)&#xD;
Positive blood culture collected during PN administration&#xD;
Concomitant antimicrobial therapy</description>
        <time_frame>Entire study period, from January 1, 2013 and December 31, 2015</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag</title>
            <description>Treatment with industrially-compounded PN formulation in three-chambered bag</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag</title>
            <description>Treatment with Hospital-compounded PN bag</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Presenting With a Confirmed Microbial Blood Stream Infection During Treatment With PN for Each Group (3CB vs HCB)</title>
          <description>Confirmation of BSI required fulfillment of all of the following criteria:&#xD;
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) code for sepsis (038.x), septicemia (995.91), severe sepsis (995.92), septic shock (785.52), bacteremia (790.7), unspecified infection due to central venous catheter (999.31), or BSI due to central venous catheter (999.32)&#xD;
Positive blood culture collected during PN administration&#xD;
Concomitant antimicrobial therapy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127"/>
                    <measurement group_id="O2" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sepsis During PN</title>
        <description>Percentage of patients presenting at least one episode of Sepsis during treatment with PN for each group (3CB vs HCB)</description>
        <time_frame>From date of admission to date of discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via an industrially-compounded three-chambered PN bag for ≥3 consecutive days during the study period</description>
          </group>
          <group group_id="O2">
            <title>Hospital-Compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Sepsis During PN</title>
          <description>Percentage of patients presenting at least one episode of Sepsis during treatment with PN for each group (3CB vs HCB)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="431"/>
                    <measurement group_id="O2" value="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment With Antimicrobials During PN</title>
        <description>Percentage of patients receiving antimicrobial agents during treatment with PN for each group (3CB vs HCB)</description>
        <time_frame>Any day during PN treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via an industrially-compounded three-chambered PN bag for ≥3 consecutive days during the study period</description>
          </group>
          <group group_id="O2">
            <title>Hospital-Compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via a Hospital-compounded all-in-one PN bag for ≥3 consecutive days during the study period</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment With Antimicrobials During PN</title>
          <description>Percentage of patients receiving antimicrobial agents during treatment with PN for each group (3CB vs HCB)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="831"/>
                    <measurement group_id="O2" value="370"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Vasopressor Treatment</title>
        <description>Percentages of patients requiring vasopressor support during PN treatment</description>
        <time_frame>Patients requiring vasopressor support at any time during treatment with PN</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Vasopressor Treatment</title>
          <description>Percentages of patients requiring vasopressor support during PN treatment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="410"/>
                    <measurement group_id="O2" value="291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Mechanical Ventilation</title>
        <description>Percentage of patients requiring mechanical ventilation during PN treatment for each group (3CB vs HCB)</description>
        <time_frame>Patients requiring mechanical ventilation at any time during PN treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Mechanical Ventilation</title>
          <description>Percentage of patients requiring mechanical ventilation during PN treatment for each group (3CB vs HCB)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="410"/>
                    <measurement group_id="O2" value="299"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal Replacement Therapy</title>
        <description>Percentage of patients requiring Renal Replacement Therapy during PN treatment for each group (3CB vs HCB)</description>
        <time_frame>Patients requiring renal replacement therapy for at least one day during PN treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Renal Replacement Therapy</title>
          <description>Percentage of patients requiring Renal Replacement Therapy during PN treatment for each group (3CB vs HCB)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Newly-occurred Abnormal Laboratory Findings During PN</title>
        <description>Percentage of patients presenting newly-occurred abnormal laboratory results during PN for each group (3CB vs HCB)</description>
        <time_frame>During PN treatment inclusive day 1</time_frame>
        <population>Simultaneous occurring laboratory abnormalities</population>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Newly-occurred Abnormal Laboratory Findings During PN</title>
          <description>Percentage of patients presenting newly-occurred abnormal laboratory results during PN for each group (3CB vs HCB)</description>
          <population>Simultaneous occurring laboratory abnormalities</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Metabolic impairment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1193"/>
                    <measurement group_id="O2" value="584"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any hepatic dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1414"/>
                    <measurement group_id="O2" value="651"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any abnormal electrolytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1444"/>
                    <measurement group_id="O2" value="699"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Organ Failure</title>
        <description>Percentage of patients presenting at least one organ failure during treatment with PN for each group (3CB vs HCB)</description>
        <time_frame>Any time during PN treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Organ Failure</title>
          <description>Percentage of patients presenting at least one organ failure during treatment with PN for each group (3CB vs HCB)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any organ failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="905"/>
                    <measurement group_id="O2" value="562"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Single organ failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="593"/>
                    <measurement group_id="O2" value="255"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiple organ failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="312"/>
                    <measurement group_id="O2" value="307"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Length of Stay (LOS)</title>
        <description>Hospital length of stay in days for patients for each group (3CB vs HCB)</description>
        <time_frame>Duration in days from admission to death or discharge for each treatment arm</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay (LOS)</title>
          <description>Hospital length of stay in days for patients for each group (3CB vs HCB)</description>
          <units>Days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26,601"/>
                    <measurement group_id="O2" value="30,384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay in the ICU</title>
        <description>Total number of days in the ICU for each group (3CB vs HCB)</description>
        <time_frame>All patients admitted in the ICU at any time during PN treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three-Chambered Bag (3CB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via industrially-compounded 3CB for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
          <group group_id="O2">
            <title>Hospital-compounded Bag (HCB)</title>
            <description>Hospitalized adults (≥18 years) who received PN containing all three major macronutrients via hospital-compounded all-in-one bag for ≥3 consecutive days during the observation period (January 1, 2013 to December 31, 2015).</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay in the ICU</title>
          <description>Total number of days in the ICU for each group (3CB vs HCB)</description>
          <units>Days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2753"/>
                <count group_id="O2" value="970"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3,017"/>
                    <measurement group_id="O2" value="3,772"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Retrospective, observational, non-interventional study. All-cause mortality, Serious and Other (Not Including Serious) Adverse Events were not monitored/assessed</time_frame>
      <desc>Not applicable since study was retrospective, observational/non-interventional. All-cause mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Three-Chambered Bag (3CB)</title>
          <description>Not applicable (Observational/non-interventional retrospective data collection)</description>
        </group>
        <group group_id="E2">
          <title>Hospital-compounded Bag (HCB)</title>
          <description>Not applicable (Observational/non-interventional retrospective data collection)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Dr. med. Martin Westphal</name_or_title>
      <organization>Fresenius Kabi Deutschland, GmbH</organization>
      <phone>+49 6172 686-7348</phone>
      <email>martin.westphal@fresenius-kabi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

